Sippican Capital Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,684
| Closed | -$165K | – | 116 |
|
|
2023
Q3 | $165K | Sell |
10,684
-70,115
| -87% | -$1.08M | 0.15% | 101 |
|
|
2023
Q2 | $1.27M | Sell |
80,799
-1,436
| -2% | -$22.6K | 1.17% | 37 |
|
|
2023
Q1 | $1.36M | Hold |
82,235
| – | – | 1.3% | 30 |
|
|
2022
Q4 | $1.28M | Sell |
82,235
-5,225
| -6% | -$81.5K | 1.23% | 35 |
|
|
2022
Q3 | $1.13M | Buy |
87,460
+1,415
| +2% | +$18.3K | 1.18% | 36 |
|
|
2022
Q2 | $1.21M | Buy |
86,045
+5,555
| +7% | +$78K | 1.2% | 36 |
|
|
2022
Q1 | $1.15M | Buy |
80,490
+10,940
| +16% | +$157K | 0.96% | 44 |
|
|
2021
Q4 | $948K | Buy |
69,550
+26,230
| +61% | +$358K | 0.81% | 51 |
|
|
2021
Q3 | $710K | Buy |
43,320
+33,110
| +324% | +$543K | 0.62% | 63 |
|
|
2021
Q2 | $172K | Buy |
+10,210
| New | +$172K | 0.15% | 111 |
|